Please Wait
Applying Filters...
menu
    • menu
    Aspen API-PSE
    News
    Proposed Divestment of Aspen Asia Pacific for R26.5 billion

    29 Dec 2025

    // PRESS RELEASE

    Aspen RxHealth Hires Chris Dattaro, COO & Jason Chicola, Independent Director

    14 Sep 2021

    // PRNEWSWIRE

    Bayer sues COVID vaccine makers over mRNA technology

    07 Jan 2026

    // REUTERS

    Data Compilation
    #PharmaFlow

    Aspen API

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/top-news-of-2025-drugmakers-invest-in-us-capacities-agree-to-lower-medicaid-prices-pfizer-buys-obesity-focused-biotech-metsera
    Menu

    Aspen Global Incorporated

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Proposed Divestment of Aspen Asia Pacific for R26.5 billion
    Proposed Divestment of Aspen Asia Pacific for R26.5 billion

    29 Dec 2025

    // PRESS RELEASE

    https://www.aspenpharma.com/proposed-divestment-of-aspen-asia-pacific-excluding-china-for-r26-5-billion/

    PRESS RELEASE
    29 Dec 2025
    Share Share
    Aspen RxHealth Hires Chris Dattaro, COO & Jason Chicola, Independent Director
    Aspen RxHealth Hires Chris Dattaro, COO & Jason Chicola, Independent Director

    14 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/aspen-rxhealth-hires-chris-dattaro-a-leader-in-gig-economy-models-as-chief-operating-officer-and-adds-jason-chicola-as-independent-director-301375828.html

    PRNEWSWIRE
    14 Sep 2021
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.